glp 1 microneedle patch Counterfeit weight loss products claiming to contain GLP-1 Single-Administration Self-Boosting Microneedle Patch for

The GLP-1 receptor agonist market size was exhibited at USD 36.95 billion in 2023 and is projected to hit around USD 261.19 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2024 to 2033.

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

Conclusion GLP1-RA therapy with liraglutide or semaglutide for 12 months is efficacious and safe for the treatment of weight regain following bariatric surgery

sales of GLP-1 drugs were $13.7 billion.

Multi-Purpose Relief: Great for everyday gas and bloating, but also effective for more intense nausea from migraines or after surgery

The inclusion of Akkermansia muciniphilaa microbe studied for its role in gut barrier health and metabolic signalingmakes this formula unique among microbiome supplements